ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,570Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1171

$950K Total Retail Price of All Prescriptions

Rank: 45 out of 1171

654 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 654 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 654 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 588 496 1 2
LEVOTHYROXINE SODIUM 527 508 2 4
OMEPRAZOLE 519 441 3 5
SIMVASTATIN 390 314 4 1
FUROSEMIDE 385 353 5 6
LISINOPRIL 383 319 6 3
DONEPEZIL HCL 375 355 7 24
METOPROLOL TARTRATE 358 280 8 11
CITALOPRAM HBR 348 320 9 22
WARFARIN SODIUM 339 293 10 12
TRAMADOL HCL 331 263 11 18
POTASSIUM CHLORIDE 312 303 12 19
NAMENDA 290 272 13 42
GABAPENTIN 248 175 14 16
METFORMIN HCL 240 161 15 7
POLYETHYLENE GLYCOL 3350 198 179 16 72
HYDROCODONE-ACETAMINOPHEN 186 163 S3 17 8
ATENOLOL 179 145 18 15
ATORVASTATIN CALCIUM 178 171 19 10
TRAZODONE HCL 176 152 20 37
SERTRALINE HCL 175 142 21 23
RISPERIDONE 174 158 22 77
GLIPIZIDE 167 129 23 47
MIRTAZAPINE 153 147 24 50
QUETIAPINE FUMARATE 147 140 25 54
METOPROLOL SUCCINATE 141 134 26 17
OXYBUTYNIN CHLORIDE ER 141 116 26 135
CARVEDILOL 133 116 28 20
PANTOPRAZOLE SODIUM 132 121 29 29
TAMSULOSIN HCL 131 120 30 28
HYDROCHLOROTHIAZIDE 130 87 31 9
LANTUS 121 107 32 46
ALBUTEROL SULFATE 116 107 33 102
DIOVAN 115 114 34 32
BUMETANIDE 112 107 35 93
FAMOTIDINE 110 101 36 75
ESCITALOPRAM OXALATE 105 80 37 69
NOVOLOG 105 79 37 94
CLONIDINE HCL 105 94 37 45
LATANOPROST 103 99 40 188
ZOLPIDEM TARTRATE 102 90 41 21
LYRICA 98 94 42 127
LEVETIRACETAM 94 45 43 84
FINASTERIDE 93 81 44 88
ADVAIR DISKUS 92 81 45 51
PRAVASTATIN SODIUM 89 70 46 13
ALLOPURINOL 89 72 46 31
DIGOXIN 87 86 48 68
FLUTICASONE PROPIONATE 83 82 49 30
SEROQUEL 83 79 49 120
TORSEMIDE 81 81 51 150
LACTULOSE 79 78 52 108
AMIODARONE HCL 78 78 53 192
GLUCAGON EMERGENCY KIT 78 75 53 311
CYMBALTA 76 50 55 64
PREDNISONE 73 71 56 39
AGGRENOX 72 60 57 148
PAROXETINE HCL 70 70 58 62
LOVASTATIN 69 61 59 36
FENTANYL 67 65 S2 60 89
RANITIDINE HCL 66 44 61 38
CLOPIDOGREL 65 62 62 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 49 63 26
SINGULAIR 63 53 64 78
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 55 65 109
LOPERAMIDE 62 41 65 262
CIPROFLOXACIN HCL 60 53 67 61
SPIRONOLACTONE 59 55 68 53
IBUPROFEN 59 38 68 80
LOSARTAN POTASSIUM 56 43 70 14
ISOSORBIDE MONONITRATE ER 55 54 71 44
LIDODERM 55 51 71 98
VESICARE 55 55 71 203
NEXIUM 54 34 74 25
NOVOLIN R 52 49 75 155
NYSTOP 51 44 76 215
OLANZAPINE 50 13 77 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.